Maximus (NYSE:MMS) Issues FY24 Earnings Guidance

Maximus (NYSE:MMS) updated its FY24 earnings guidance on Wednesday. The company provided EPS guidance of $5.65-5.85 for the period, compared to the consensus EPS estimate of $5.41. The company issued revenue guidance of $5.15-5.25 billion, compared to the consensus revenue estimate of $5.17 billion.

Maximus Price Performance

NYSE MMS traded down $0.13 during trading on Wednesday, reaching $84.12. The company’s stock had a trading volume of 412,403 shares, compared to its average volume of 324,740. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.69 and a quick ratio of 1.69. The firm has a fifty day moving average of $82.33 and a 200 day moving average of $81.61. The stock has a market capitalization of $5.13 billion, a PE ratio of 27.90 and a beta of 0.72. Maximus has a one year low of $72.39 and a one year high of $89.69.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Wednesday, February 7th. The health services provider reported $1.34 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.06. Maximus had a net margin of 3.73% and a return on equity of 15.68%. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.29 billion. During the same period last year, the business earned $0.94 earnings per share. The business’s quarterly revenue was up 6.2% on a year-over-year basis. Analysts expect that Maximus will post 5.42 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date is Tuesday, May 14th. Maximus’s dividend payout ratio (DPR) is presently 39.74%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Maximus from a hold rating to a buy rating in a research report on Thursday, February 8th.

Insider Buying and Selling

In other Maximus news, CFO David Mutryn sold 8,000 shares of the business’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $83.95, for a total transaction of $671,600.00. Following the transaction, the chief financial officer now directly owns 5,124 shares of the company’s stock, valued at approximately $430,159.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.40% of the stock is owned by insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.